Tesla Inc.'s (NASDAQ:TSLA) rally isn't just about EVs anymore — it's about who owns the future of robotics. As shares hover near 2025 highs, investors are increasingly treating autonomy, Optimus, and Robotaxi ambitions as core drivers of value rather than…
Strategy Inc. (NASDAQ:MSTR) disclosed another major Bitcoin (CRYPTO: BTC) purchase on Monday, acquiring 10,645 BTC for about $980.3 million between Dec. 8 and Dec. 14, even as a key performance metric behind its stock turns negative. Strategy Extends Bitcoin Accumulation…
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.1% on Monday. Following the market opening Monday, the Dow traded up 0.09% to 48,502.84 while the NASDAQ fell 0.03% to 23,187.60. The S&P 500 also rose,…
In the current market session, Five Below Inc. (NASDAQ:FIVE) stock price is at $182.49, after a 0.50% decrease. However, over the past month, the company's stock increased by 23.42%, and in the past year, by 73.31%. Shareholders might be interested…
In the dynamic and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Amazon.com (NASDAQ:AMZN) and its primary competitors in the Broadline Retail…
In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Microsoft (NASDAQ:MSFT) and its primary competitors in the Software industry.…
The question of whether the rally in AI stocks has turned into a bubble has been top of mind for investors lately. Wall Street investment banks have offered very different explanations: some warn that enthusiasm has gone too far, while…
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) stock rose Monday, with a session volume of 6.80 million compared to the average volume of 696.68 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2…
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) stock rose Monday, with a session volume of 6.80 million compared to the average volume of 696.68 thousand as per data from Benzinga Pro. The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2…
ServiceNow (NYSE:NOW) is reportedly in advanced talks to acquire cybersecurity firm Armis, which could value the startup at up to $7 billion, according to people familiar with the matter. The transaction could be announced in the coming days, though negotiations are…